key: cord-0952318-maf0kwzc
authors: Saramago, Margarida; Bárria, Cátia; Costa, Vanessa; Souza, Caio S.; Viegas, Sandra C.; Domingues, Susana; Lousa, Diana; Soares, Cláudio M; Arraiano, Cecília M; Matos, Rute G.
title: New targets for drug design: Importance of nsp14/nsp10 complex formation for the 3’-5’ exoribonucleolytic activity on SARS-CoV-2
date: 2021-01-07
journal: bioRxiv
DOI: 10.1101/2021.01.07.425745
sha: b8e852b1d6c0e507aa0d01d2a629739bfdbb662a
doc_id: 952318
cord_uid: maf0kwzc

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has triggered a global pandemic with devastating consequences for health-care and social-economic systems. Thus, the understanding of fundamental aspects of SARS-CoV-2 is of extreme importance. In this work, we have focused our attention on the viral ribonuclease (RNase) nsp14, since this protein was considered one of the most interferon antagonists from SARS-CoV-2, and affects viral replication. This RNase is a multifunctional protein that harbors two distinct activities, an N-terminal 3’-to-5’ exoribonuclease (ExoN) and a C-terminal N7-methyltransferase (N7-MTase), both with critical roles in coronaviruses life cycle. Namely, SARS-CoV-2 nsp14 ExoN knockout mutants are non-viable, indicating nsp14 as a prominent target for the development of antiviral drugs. Nsp14 ExoN activity is stimulated through the interaction with the nsp10 protein, which has a pleiotropic function during viral replication. In this study, we have performed the first biochemical characterization of the complex nsp14-nsp10 from SARS-CoV-2. Here we confirm the 3’-5’ exoribonuclease and MTase activities of nsp14 in this new Coronavirus, and the critical role of nsp10 in upregulating the nsp14 ExoN activity in vitro. Furthermore, we demonstrate that SARS-CoV-2 nsp14 N7-MTase activity is functionally independent of the ExoN activity. The nsp14 MTase activity also seems to be independent of the presence of nsp10 cofactor, contrarily to nsp14 ExoN. Until now, there is no available structure for the SARS-CoV-2 nsp14-nsp10 complex. As such, we have modelled the SARS-CoV-2 nsp14-nsp10 complex based on the 3D structure of the complex from SARS-CoV (PDB ID 5C8S). We also have managed to map key nsp10 residues involved in its interaction with nsp14, all of which are also shown to be essential for stimulation of the nsp14 ExoN activity. This reinforces the idea that a stable interaction between nsp10 and nsp14 is strictly required for the nsp14-mediated ExoN activity of SARS-CoV-2, as observed for SARS-CoV. We have studied the role of conserved DEDD catalytic residues of SARS-CoV-2 nsp14 ExoN. Our results show that motif I of ExoN domain is essential for the nsp14 function contrasting to the functionality of these conserved catalytic residues in SARS-CoV, and in the Middle East respiratory syndrome coronavírus (MERS). The differences here revealed can have important implications regarding the specific pathogenesis of SARS-CoV-2. The nsp10-nsp14 interface is a recognized attractive target for antivirals against SARS-CoV-2 and other coronaviruses. This work has unravelled a basis for discovering inhibitors targeting the specific amino acids here reported, in order to disrupt the assembly of this complex and interfere with coronaviruses replication.

CoV nsp14 was discovered to be a bifunctional protein, since beyond its 140 exoribonucleolytic activity it also displays a guanine-N7-methyltransferase (N7-MTase) 141 activity in its C-terminal domain [18] . This means that the enzyme is capable of nsp16 in complex with its activator nsp10 to give rise to cap-1 7Me GpppA2'OMe-RNAs. 152 While nsp14 recognizes non-methylated RNA cap exclusively, nsp10/nsp16 recognizes 153 N7-methylated RNA cap [20] . 154 Coronaviruses have the inherent capacity to mutate, recombine and infect different hosts. 155 This raises an urgent need for the development of effective antiviral drugs to fight against 156 the present and future pandemic diseases that may arise. Through its dual function, nsp14 understanding of nsp14/nsp10 mechanisms of action, this work will also help to clarify 164 its role in the SARS-CoV-2 life cycle. Importantly, it will serve as a basis for the design 165 of effective drugs to treat Covid-19 and other CoVs infections. Benzonase (Sigma) to degrade the nucleic acids and clarified by a 30 min centrifugation at 10 000 xg. Purification was performed in an ÄKTA FPLC™ system (GE Healthcare). 197 The cleared lysate was subjected to a histidine affinity chromatography in a HisTrap HP The final model was further used as the template for modeling the structures of the mutant 301 proteins. Only the substituted residue and its neighboring residues (within 6 Å) were 302 refined during the modeling process. First, we intended to test the ribonuclease activity of the purified SARS-CoV-2 nsp14. 318 We have used the synthetic RNA substrate H4 previously reported in Bouvet et al. [16] .

This substrate is a 22-nucleotide (nt) long RNA with a 5' single-stranded (ss) tail and a 320 3'-end engaged in a stable duplex structure ( Figure S2 ). The nsp14 ExoN activity was 321 then determined by analyzing the hydrolysis of the H4 RNA 5'-end radiolabeled. As we 322 can see in the left panel of Figure 1A , nsp14 alone exhibits exoribonucleolytic activity; 323 however, in the conditions tested (40 nM of nsp14), the activity was not pronounced.

( Figure 1A ). Nsp10 was previously reported as a critical co-factor for activation of nsp14 nsp10 alone (at 160 nM, which was the higher concentration used in nsp10:nsp14 ratio) 343 for ribonucleolytic activity under the same conditions used for nsp14. As expected, nsp10 344 was not able to degrade the RNA substrate ( Figure 1A ).

The ability of nsp10 to interact with nsp14 was analyzed through Surface Plasmon 346 Resonance (SPR) ( Figure 1B ). For this, purified nsp14 was immobilized in a sensor chip 347 and nsp10 was injected at different concentrations as described in materials and methods.

The results confirm that both proteins interact with each other as showed by an increased 349 response when nsp10 is injected. This increase is dependent on nsp10 concentrations and 350 it is possible to see the dissociation of nsp10 over time when injection stops. Since nsp14 351 or nsp10 were shown to be very unstable proteins, it was not possible to obtain a good fit 352 of the data in order to determine the binding kinetics and dissociation constants. 353 We have also co-purified nsp10 and nsp14 proteins. During the size exclusion . Surprisingly, fraction 20, which appears to have more nsp14 compared to nsp10, 364 was the most active sample. This fraction showed the ability of totally consuming the 365 RNA, starting with the ds-region and then proceeding to the ss-region of the substrate, 366 generating products of smaller size. With 50 nM of this fraction, the degradation proceeds 367 until it reaches a unique and final product of 8-nts ( Figure S4 ). This result is in line with 368 the reported ability of SARS-CoV nsp14 to hydrolyze ssRNA to end products of 8-12 nts 369 [16; 26]. Finally, fractions 10 (excess of nsp14) and 24 (excess of nsp10) present a similar 370 ability to cleave the H4 RNA. The activity of these fractions was comparable to that 371 observed when testing nsp14 and nsp10 mixed together in the 1:4 ratio ( Figure 1C ). We 372 can conclude that co-purifying nsp14 and nsp10 proteins substantially increases nsp14 373 ExoN activity, and, in this case, the ratio between them seems not to be determinant to 374 achieve high levels of ExoN activity. However, taking into account that our intention was apparently completely lost their ability to interact with nsp14 WT in these conditions.

According to our homology model represented in Figure 4D , the alanine substitutions The residue G69 is located in a known structural motif that links the nsp10 sheet β2 to 454 the helix H3 ( Figure 4D ). This motif is part of an extensive region of intermolecular 455 interactions between nsp10 and nsp14 that also helps on the stabilization of the ExoN Figure S1 ). We conducted activity assays using these variants in order to assess the role Figure 5C , mutations on these residues influenced the ExoN activity of SARS-518 CoV-2 nsp14. E92A substitution had the most striking effect, presenting only residual 519 exoribonuclease activity. Although to a less extent, the D90A mutant was also severely 520 deficient in their ability to degrade RNA and rendered a major product of 19 nts. These 521 results demonstrate the importance of residues from motif I (D90 and E92) for the activity 522 of nsp14. In contrast, mutations in aspartates from motifs II and III (D243A and D273A, 523 respectively) led to a modest reduction in the ExoN activity, both being able to fully 524 degrade the full-length RNA after 60 min of incubation ( Figure 5C ). However, the 525 cleavage patterns generated with both mutants were different. The nsp14 D273A version 526 yielded products ranging between 17-and 20-nts (more similar to that of WT), whereas 527 the D243A mutant generated major products between 18-and 20-nts. However, this 528 mutant version was able to go further in the degradation since smaller minor products 529 could be detected ( Figure 5C) . 530 Due to the extra role of the motif I E92 residue, it is likely that the substitution E92A 531 causes a major impact on the catalysis compared to the mutations D243A and D273A.

The residue D90 also coordinates an Mg 2+ ion ( Figure 5A ), but surprisingly the impact of 533 the mutation D90A was not as severe as the observed on E92A. Probably the presence of 534 the residue E191 may be sufficient to keep the Mg 2+ ion in the active site, attenuating the 535 effects of the D90A substitution. This behavior is consistent with the data from SARS- 536 CoV that shows that the E191 mutation is more likely to affect the ExoN activity than the CoV-2 nsp14 to test its N7-MTase activity, using capped 30-mer G*ppp-RNA as 555 substrate ( Figure 6 ). An nsp14 D331A mutant was constructed and used as a negative that co-migrates with m 7 G*pppG marker ( Figure 6A ). In contrast, treatment of 564 G*pppRNA with nsp14 D331A mutant did not generate a similar product on the TLC 565 plate ( Figure 6A ). Instead, it gives a nucleotide product that co-migrates with G*pppG 566 marker resultant from the digestion of G*pppRNA with P1 nuclease.

To evaluate if the nsp14 ExoN activity has any influence on the SARS-CoV-2 MTase 568 activity, the point mutations located in the conserved motifs of the ExoN domain (D90A, 569 E92A, D243A and D273A) were also tested for their capacity to methylate the 570 G*pppRNA in the presence of SAM. As shown in Figure 6B , none of these substitutions CoV-2, the coronavirus responsible for the current COVID-19 pandemic.

Nsp10 residues involved in the interaction with nsp14 were found to be essential for 

Although the 3D structure of the SARS-CoV-2 nsp14-nsp10 complex is not yet solved, 601 our work gave the first insights into important SARS-CoV-2 nsp10 residues directly 602 involved in the interaction with nsp14. This is here demonstrated by the SPR data, as 603 inferred by the homology model done on the basis of the SARS-CoV experimentally 604 determined structure, and the high sequence identity between the proteins from the two 605 viruses. We demonstrate that mutations in the nsp10 F19, G69, S72, H80 and Y96 amino 606 acids residues have deleterious consequences for the nsp14 ExoN activity in vitro, which 607 could be rationalized by the structural effects that these mutations have in the formation 608 of the nsp10-nsp14 heterodimer. Therefore, we infer that a stable interaction between 609 these two proteins is strictly required for the correct functioning of nsp14 ExoN activity Our results highlighted nsp10 as a potential target for antiviral drug development. We 629 propose some nsp10 residues that can be targeted to disrupt both the nsp14-nsp10 and the 

Characteristics of SARS-CoV-2 and COVID-19

Human Coronavirus: Host-Pathogen Interaction. Annual review of 788 microbiology

The critical role of 791 RNA processing and degradation in the control of gene expression

The 794 importance of proteins of the RNase II/RNB-family in pathogenic bacteria

Ribonucleases, antisense RNAs 797 and the control of bacterial plasmids

The role of RNases in the regulation of small RNAs

The Implication of mRNA 802 Degradation Disorders on Human DISease: Focus on DIS3 and DIS3-Like Enzymes

The Curious 805 Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication 806 Fidelity

Exoribonuclease superfamilies: structural analysis and 808 phylogenetic distribution

Structural basis for the 3'-5' exonuclease activity of Escherichia 810 coli DNA polymerase I: a two metal ion mechanism

Purification and characterization of Escherichia coli 813

A general two-metal-ion mechanism for catalytic RNA

Unique and conserved features of genome 819 and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 820 lineage

The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for 828 Replication of MERS-CoV and SARS-CoV-2

RNA 3'-end mismatch 830 excision by the severe acute respiratory syndrome coronavirus nonstructural protein 831 nsp10/nsp14 exoribonuclease complex

834 Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. 835 Proceedings of the National Academy of Sciences of the United States of America

Functional screen reveals 838 SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. 839 Proceedings of the National Academy of Sciences of the United States of America

842 Characterization of the guanine-N7 methyltransferase activity of coronavirus nsp14 on 843 nucleotide GTP

Biochemical and structural insights into the mechanisms of 846 SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex

Oligoribonucleotide 849 synthesis using T7 RNA polymerase and synthetic DNA templates

Comparative protein modelling by satisfaction of spatial 852 restraints

Statistical potential for assessment and prediction of protein 854 structures. Protein science : a publication of the

Coronavirus Nsp10, a critical co-factor for activation of multiple replicative 858 enzymes

Dodecamer structure of severe acute respiratory syndrome coronavirus 861 nonstructural protein nsp10

Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in 864 coronavirus RNA synthesis

Characterisation of 868 the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral 869 genome stability and inhibitor identification

Biochemical characterization of 871 exoribonuclease encoded by SARS coronavirus

Sinorhizobium meliloti YbeY is an endoribonuclease 875 with unprecedented catalytic features, acting as silencing enzyme in riboregulation

Sinorhizobium meliloti RNase III: Catalytic Features and Impact on Symbiosis

Genetic and crystallographic studies of the 3',5'-exonucleolytic site of DNA 882 polymerase I

Crystal Structure of Non-Structural 885 Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2. International 886 journal of molecular sciences

Murine hepatitis 888 virus replicase protein nsp10 is a critical regulator of viral RNA synthesis

Molecular mapping of the RNA 892 Cap 2'-O-methyltransferase activation interface between severe acute respiratory 893 syndrome coronavirus nsp10 and nsp16

High-resolution epitope mapping of hGH-receptor 896 interactions by alanine-scanning mutagenesis

898 Structure-function analysis of severe acute respiratory syndrome coronavirus RNA cap 899 guanine-N7-methyltransferase

In vitro 901 reconstitution of SARS-coronavirus mRNA cap methylation

Infidelity of SARS-CoV Nsp14-905 exonuclease mutant virus replication is revealed by complete genome sequencing

High fidelity of murine hepatitis 908 virus replication is decreased in nsp14 exoribonuclease mutants

Structural and molecular basis of 912 mismatch correction and ribavirin excision from coronavirus RNA

Crystal 915 structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral 916 drug design

Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived 919

Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis

Proofreading-922 Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without 923 Reversion of Exoribonuclease-Inactivating Mutations

Coronaviruses lacking 925 exoribonuclease activity are susceptible to lethal mutagenesis: evidence for 926 proofreading and potential therapeutics

Coronavirus Susceptibility to the Antiviral Remdesivir

Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Remdesivir and SARS-CoV-2: Structural requirements at both 934 nsp12 RdRp and nsp14 Exonuclease active-sites

In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and 936 repurposing of FDA approved antiviral drugs as dual inhibitors

Innate immune restriction and antagonism of viral RNA 939 lacking 2-O methylation

2'-O methylation of the viral mRNA cap evades host 943 restriction by IFIT family members

mRNA capping: biological functions and 945 applications

RIG-I-like receptors: their regulation and roles in RNA 947 sensing

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as 950 potent interferon antagonists. Emerging microbes & infections 9

Severe 953 acute respiratory syndrome coronavirus E protein transports calcium ions and 954 activates the NLRP3 inflammasome

Interaction of viral proteins with metal ions: role in 956 maintaining the structure and functions of viruses

RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex

 768 We are grateful to the distinguished and experienced virologists Miguel Fevereiro and 769 Margarida Henriques (INIAV, Lisbon, Portugal) for the valuable discussions regarding 770 physiology of SARS-CoV-2. We also thank Teresa Batista da Silva for technical support.

 Tables   Table S1 . Primers